Auris Medical Holding (EARS) Reports In-Line Q2 Loss

Auris Medical Holding (NASDAQ: EARS) reported Q2 EPS of (CHF0.25), in-line with the analyst estimate of (CHF0.25).

Cash and cash equivalents at June 30, 2016, totaled CHF 32.8 million, which does not include the $12.5 million received in July 2016 as part of the loan facility.

For earnings history and earnings-related data on Auris Medical Holding (EARS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c